E79.1 Lesch-Nyhan syndrome

Name of the Condition

• Lesch-Nyhan syndrome (ICD-10 Code: E79.1)

Summary

Lesch-Nyhan syndrome is a rare X-linked recessive genetic disorder characterized by overproduction of uric acid, neurological dysfunction, and self-injurious behavior. It results from a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which disrupts purine metabolism. The condition typically presents in early childhood with a combination of motor, cognitive, and behavioral symptoms.

Causes

Lesch-Nyhan syndrome is caused by mutations in the HPRT1 gene, which encodes the HGPRT enzyme. These mutations impair the enzyme's ability to recycle purines, leading to excessive uric acid production. The disorder is inherited in an X-linked recessive pattern, meaning it primarily affects males, while females are usually carriers.

Risk Factors

• Male sex (due to X-linked inheritance).
• Family history of Lesch-Nyhan syndrome or related metabolic disorders.
• Consanguinity (increased risk of inheriting recessive genetic mutations).

Symptoms

• Neurological: Developmental delay, dystonia, spasticity, and choreoathetosis.
• Behavioral: Compulsive self-injurious behavior (e.g., lip/cheek biting, head banging).
• Metabolic: Hyperuricemia leading to gout, kidney stones, or nephropathy.
• Cognitive: Intellectual disability, often severe.

Diagnosis

Diagnosis is confirmed through a combination of clinical evaluation, measurement of uric acid levels, and genetic testing for HPRT1 mutations. Enzyme activity assays in red blood cells or fibroblasts may also be used to assess HGPRT function. Early diagnosis is critical for managing symptoms and complications.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Allopurinol reduces uric acid levels to prevent gout and kidney disease. Neurological symptoms may be addressed with medications (e.g., benzodiazepines, baclofen) or physical therapy. Behavioral interventions and protective measures (e.g., restraints) are used to manage self-injury.

Prognosis and Follow-Up

Prognosis is poor, with most individuals requiring lifelong care. Complications like kidney disease or infections can reduce lifespan. Regular monitoring of uric acid, renal function, and neurological status is essential. Supportive care, including occupational and behavioral therapy, improves quality of life.

Complications

• Chronic kidney disease or renal failure from uric acid nephropathy.
• Recurrent gout or tophi.
• Severe neurological impairment or contractures.
• Increased risk of infections due to self-injury or immobility.

Lifestyle & Prevention

• Genetic counseling for families with a history of the disorder.
• Prenatal testing (e.g., chorionic villus sampling) for at-risk pregnancies.
• Avoidance of purine-rich foods to help manage uric acid levels (though not curative).

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden onset of severe pain (e.g., gout, kidney stones).
• Unexplained behavioral changes or self-injury.
• Signs of infection (e.g., fever, redness) from self-inflicted wounds.
• Neurological deterioration (e.g., worsening spasms, loss of mobility).

Tips for Medical Coders

• Document the presence of hyperuricemia, neurological symptoms, and self-injurious behavior to support the diagnosis.
• Include details on genetic testing or enzyme activity results if available.
• Note any associated complications (e.g., gout, renal disease) for accurate coding.
• Ensure the code is linked to relevant clinical documentation for reimbursement and reporting.